NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
27.96
+0.29 (1.05%)
Aug 7, 2026, 4:00 PM EDT - Market closed

NAMS Statistics

Total Valuation

NAMS has a market cap or net worth of $3.27 billion. The enterprise value is $2.59 billion.

Market Cap3.27B
Enterprise Value 2.59B

Important Dates

The last earnings date was Wednesday, August 5, 2026, before market open.

Earnings Date Aug 5, 2026
Ex-Dividend Date n/a

Share Statistics

NAMS has 116.90 million shares outstanding. The number of shares has increased by 11.62% in one year.

Current Share Class 116.90M
Shares Outstanding 116.90M
Shares Change (YoY) +11.62%
Shares Change (QoQ) +1.33%
Owned by Insiders (%) 0.34%
Owned by Institutions (%) 73.82%
Float 80.70M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 459.01
Forward PS 185.48
PB Ratio 5.21
P/TBV Ratio 5.18
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 363.78
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.03, with a Debt / Equity ratio of 0.00.

Current Ratio 9.03
Quick Ratio 8.69
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -36.81% and return on invested capital (ROIC) is -21.66%.

Return on Equity (ROE) -36.81%
Return on Assets (ROA) -20.11%
Return on Invested Capital (ROIC) -21.66%
Return on Capital Employed (ROCE) -38.97%
Weighted Average Cost of Capital (WACC) 4.86%
Revenue Per Employee $71,210
Profits Per Employee -$2.60M
Employee Count100
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +18.37% in the last 52 weeks. The beta is 0.11, so NAMS's price volatility has been lower than the market average.

Beta (5Y) 0.11
52-Week Price Change +18.37%
50-Day Moving Average 31.46
200-Day Moving Average 33.60
Relative Strength Index (RSI) 38.63
Average Volume (20 Days) 1,028,488

Short Selling Information

The latest short interest is 9.18 million, so 9.22% of the outstanding shares have been sold short.

Short Interest 9.18M
Short Previous Month 9.09M
Short % of Shares Out 9.22%
Short % of Float n/a
Short Ratio (days to cover) 8.63

Income Statement

In the last 12 months, NAMS had revenue of $7.12 million and -$259.50 million in losses. Loss per share was -$2.16.

Revenue7.12M
Gross Profit 7.12M
Operating Income -244.41M
Pretax Income -259.50M
Net Income -259.50M
EBITDA -245.74M
EBIT -246.10M
Loss Per Share -$2.16
Full Income Statement

Balance Sheet

The company has $633.85 million in cash and $82,000 in debt, with a net cash position of $678.18 million or $5.80 per share.

Cash & Cash Equivalents 633.85M
Total Debt 82,000
Net Cash 678.18M
Net Cash Per Share $5.80
Equity (Book Value) 631.42M
Book Value Per Share 5.37
Working Capital 586.23M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$143.46 million and capital expenditures -$260,000, giving a free cash flow of -$143.72 million.

Operating Cash Flow -143.46M
Capital Expenditures -260,000
Depreciation & Amortization 244,000
Net Borrowing n/a
Free Cash Flow -143.72M
FCF Per Share -$1.23
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -3,432.20%
Pretax Margin -3,644.21%
Profit Margin n/a
EBITDA Margin -3,450.88%
EBIT Margin -3,455.95%
FCF Margin n/a

Dividends & Yields

NAMS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -11.62%
Shareholder Yield -11.62%
Earnings Yield -7.94%
FCF Yield -4.40%

Analyst Forecast

The average price target for NAMS is $51.40, which is 83.83% higher than the current price. The consensus rating is "Strong Buy".

Price Target $51.40
Price Target Difference 83.83%
Analyst Consensus Strong Buy
Analyst Count 16
Revenue Growth Forecast (3Y) 157.50%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1